NEKTAR THERAPEUTICS

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

NEKTAR THERAPEUTICS

Social Links:

Twitter

Industry:

Biotechnology Chemical Health Care Therapeutics

Founded:

1990-01-01

Address:

San Carlos, California, United States

Country:

United States

Website Url:

http://www.nektar.com

Total Employee:

501+

Status:

Active

Contact:

(650)631-3100

Email Addresses:

[email protected]

Total Funding:

1.17 B USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Apache

Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

feldan-therapeutics-logo

Feldan Therapeutics

Feldan Therapeutics has developed a patented peptide-based technology platform.

glycan-therapeutics-logo

Glycan Therapeutics

Glycan Therapeutics develops drug therapies based on a novel synthetic carbohydrate technology platform.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

Current Advisors List

not_available_image

Dennis Winger Member of the Board of Directors @ Nektar Therapeutics
Board_member
2009-12-01

not_available_image

Christopher Kuebler Member of the Board of Directors @ Nektar Therapeutics
Board_member
2001-12-01

not_available_image

Lutz Lingnau Member of the Board of Directors @ Nektar Therapeutics
Board_member
2007-08-01

not_available_image

Roy Whitfield Member of the Board of Directors @ Nektar Therapeutics
Board_member
2000-08-01

scott-greer_image

Scott Greer Member of the Board of Directors @ Nektar Therapeutics
Board_member
2010-02-01

howard-robin_image

Howard Robin Member of the Board of Directors @ Nektar Therapeutics
Board_member
2007-01-01

Current Employees Featured

jillian-b-thomsen_image

Jillian B. Thomsen
Jillian B. Thomsen SVP Finance & Chief Accounting Officer @ Nektar Therapeutics
SVP Finance & Chief Accounting Officer
2008-04-01

jillian-b-thomsen_image

Jillian B. Thomsen
Jillian B. Thomsen Senior Vice President & Chief Financial Officer @ Nektar Therapeutics
Senior Vice President & Chief Financial Officer
2022-07-01

kevin-brodbeck_image

Kevin Brodbeck
Kevin Brodbeck Senior Vice President of Manufacturing @ Nektar Therapeutics
Senior Vice President of Manufacturing

robert-medve_image

Robert Medve
Robert Medve Senior Vice President and Chief Medical Officer @ Nektar Therapeutics
Senior Vice President and Chief Medical Officer
2011-03-01

dorian-hirth_image

Dorian Hirth
Dorian Hirth Senior Vice President, Human Resources and Facilities Operations @ Nektar Therapeutics
Senior Vice President, Human Resources and Facilities Operations

howard-robin_image

Howard Robin
Howard Robin President and Chief Executive Officer @ Nektar Therapeutics
President and Chief Executive Officer
2007-01-01

timothy-a-riley_image

Timothy A. Riley
Timothy A. Riley Senior Vice President, Technology Assessment and Quality Assurance @ Nektar Therapeutics
Senior Vice President, Technology Assessment and Quality Assurance

jonathan-polak_image

Jonathan Polak
Jonathan Polak Chief Commercial Officer @ Nektar Therapeutics
Chief Commercial Officer
2019-12-01

mary-tagliaferri_image

Mary Tagliaferri
Mary Tagliaferri Senior Vice President, Executive Clinical Fellow & Chief Medical Officer @ Nektar Therapeutics
Senior Vice President, Executive Clinical Fellow & Chief Medical Officer
2017-04-01

wei-lin_image

Wei Lin
Wei Lin Senior Vice President & Head of Development @ Nektar Therapeutics
Senior Vice President & Head of Development
2016-05-01

Founder

john-s-patton_image

John S. Patton

Stock Details

Company's stock symbol is NASDAQ:NKTR

Acquisitions List

Date	Company	Article	Price
2005-10-21	Aerogen, Inc.	Aerogen, Inc. acquired by Nektar Therapeutics	32 M USD
2001-07-02	Shearwater Corp.	Shearwater Corp. acquired by Nektar Therapeutics	164 M USD

Investors List

sfj-pharmaceuticals_image

Investments List

Date	Company	Article	Money raised
2008-07-03	Pearl Therapeutics	Nektar Therapeutics investment in Series A - Pearl Therapeutics	18 M USD

Newest Events participated

Participated in Oncology Strategy Meeting US West Coast 2018 on 2018-05-14 as speaker

Key Employee Changes

Date	New article
2022-07-01	Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer
2019-12-04	Nektar Therapeutics Names John Northcott Chief Commercial Officer

Official Site Inspections

http://www.nektar.com Semrush global rank: 1.81 M Semrush visits lastest month: 12.57 K

Host Informations
Whois Informations

Loading ...